The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
Pan, G., Ni, J., Wei, Y.-F., Yu, G.-L., Gentz, R., & Dixit, V. M. (1997) · Science · doi:10.1126/science.277.5327.815 · Cited by 1,496
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
Jo, M., Kim, T.-H., Seol, D.-W., Esplen, J. E., Dorko, K., Billiar, T. R., & Strom, S. C. (2000) · Nature Medicine · doi:10.1038/75045 · Cited by 843
Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., & Goodwin, R. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80399-4 · Cited by 821
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., & Hood, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80400-8 · Cited by 711
Chun, H. J., Zheng, L., Ahmad, M., Wang, J., Speirs, C. K., Siegel, R. M., Dale, J. K., Puck, J., Davis, J., Hall, C. G., et al. (2002) · Nature · doi:10.1038/nature01063 · Cited by 708
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 649
Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van Dongen, J. L., Gilfillan, M. C., Shiels, H., Hardwick, J. M., & Thompson, C. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00629.x · Cited by 633
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H., & Kirchhoff, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101780200 · Cited by 566
Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL
MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernandes-Alnemri, T., Cohen, G. M., & Alnemri, E. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25417 · Cited by 557
FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis
Krueger, A., Baumann, S., Krammer, P. H., & Kirchhoff, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8247-8254.2001 · Cited by 549
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., Gazdar, A., Blenis, J., Arnott, D., & Ashkenazi, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105102200 · Cited by 536
From receptors to stress-activated MAP kinases
Ichijo, H. (1999) · Oncogene · doi:10.1038/sj.onc.1203129 · Cited by 524
LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., & Ashkenazi, A. (2002) · Nature Medicine · doi:10.1038/nm0302-274 · Cited by 507
Fulda, S., Küfer, M. U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204750 · Cited by 404
Caspase-10 is an initiator caspase in death receptor signaling
Wang, J., Chun, H. J., Wong, W., Spencer, D. M., & Lenardo, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241358198 · Cited by 401
Casper Is a FADD- and Caspase-Related Inducer of Apoptosis
Shu, H.-B., Halpin, D. R., & Goeddel, D. V. (1997) · Immunity · doi:10.1016/s1074-7613(00)80450-1 · Cited by 399
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
Fulda, S., Meyer, E., & Debatin, K.-M. (2002) · Oncogene · doi:10.1038/sj.onc.1205258 · Cited by 394
I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis
Hu, S., Vincenz, C., Ni, J., Gentz, R., & Dixit, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17255 · Cited by 377
Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim, K., Fisher, M. J., Xu, S., & El‐Deiry, W. S. (2000) · PubMed · Cited by 376
Sprick, M. R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf441 · Cited by 363
FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis
Srinivasula, S. M., Ahmad, M., Ottilie, S., Bullrich, F., Banks, S., Wang, Y., Fernandes-Alnemri, T., Croce, C. M., Litwack, G., Tomaselli, K. J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18542 · Cited by 335
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
Medema, J. P., de Jong, J., van Hall, T., Melief, C. J. M., & Offringa, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.1033 · Cited by 330
CASH, a Novel Caspase Homologue with Death Effector Domains
Goltsev, Y. V., Kovalenko, A. V., Arnold, E., Varfolomeev, E. E., Brodianskii, V. M., & Wallach, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19641 · Cited by 318
Rasper, D. M., Vaillancourt, J. P., Hadano, S., Houtzager, V. M., Seiden, I., Keen, S. L., Tawa, P., Xanthoudakis, S., Nasir, J., Martindale, D., et al. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400370 · Cited by 316
CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
Inohara, N., Koseki, T., Hu, Y., Chen, S., & Núñez, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10717 · Cited by 315
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis
Hinz, S., Trauzold, A., Boenicke, L., Sandberg, C., Beckmann, S., Bayer, E., Walczak, H., Kalthoff, H., & Ungefroren, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203936 · Cited by 275
Ehrhardt, H., Fulda, S., Schmid, I., Hiscott, J., Debatin, K.-M., & Jeremias, I. (2003) · Oncogene · doi:10.1038/sj.onc.1206520 · Cited by 272
Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., & Stahel, R. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401157 · Cited by 270
Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N., & Brodeur, G. M. (2001) · PubMed · Cited by 267
Kataoka, T., Schröter, M., Hahne, M., Schneider, P., Irmler, M., Thome, M., Froelich, C. J., & Tschopp, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3936 · Cited by 243
Shankar, S., & Srivastava, R. K. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.03.002 · Cited by 237
Han, D. K. M., Chaudhary, P. M., Wright, M. E., Friedman, C., Trask, B. J., Riedel, R. T., Baskin, D. G., Schwartz, S. M., & Hood, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11333 · Cited by 235
Death-effector Filaments: Novel Cytoplasmic Structures that Recruit Caspases and Trigger Apoptosis
Siegel, R. M., Martin, D. A., Zheng, L., Ng, S. Y., Bertin, J., Cohen, J., & Lenardo, M. J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1243 · Cited by 234
FADD Is Required for DR4- and DR5-mediated Apoptosis
Kuang, A. A., Diehl, G. E., Zhang, J., & Winoto, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000284200 · Cited by 232
Shin, M. S., Kim, H. S., Lee, S. H., Park, W. S., Kim, S. Y., Park, J. Y., Lee, J. H., Lee, S., Lee, S. N., Jung, S. S., et al. (2001) · PubMed · Cited by 229
Zhang, X. D., Zhang, X., Gray, C. P., Nguyen, T., & Hersey, P. (2001) · PubMed · Cited by 228
Kandasamy, K., Srinivasula, S. M., Alnemri, E. S., Thompson, C. B., Korsmeyer, S. J., Bryant, J., & Srivastava, R. K. (2003) · PubMed · Cited by 222
Zhang, X. D., Nguyen, T., Thomas, W. D., Sanders, J. E., & Hersey, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02042-1 · Cited by 218
Chen, X., Kandasamy, K., & Srivastava, R. K. (2003) · PubMed · Cited by 213
The kiss of death: promises and failures of death receptors and ligands in cancer therapy
Daniel, P., Wieder, T., Sturm, I., & Schulze-Osthoff, K. (2001) · Leukemia · doi:10.1038/sj.leu.2402169 · Cited by 198
Harper, N., Farrow, S. N., Kaptein, A., Cohen, G. M., & MacFarlane, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105693200 · Cited by 187
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.
Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (1999) · PubMed · Cited by 179
Rare loss-of-function mutation of a death receptor gene in head and neck cancer.
Pai, S. I., Wu, G. S., Özören, N., Li, W., Jen, J., Sidransky, D., & El‐Deiry, W. S. (1998) · PubMed · Cited by 179
Zhang, X. D., Borrow, J. M., Zhang, X. Y., Nguyen, T., & Hersey, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206427 · Cited by 163
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma
Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204103 · Cited by 162
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Wang, Y., Engels, I. H., Knee, D. A., Nasoff, M., Deveraux, Q. L., & Quon, K. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00113-8 · Cited by 161
Wajant, H., Johannes, F., Haas, E., Siemienski, K., Schwenzer, R., Schubert, G., Weiß, T., Grell, M., & Scheurich, P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70042-9 · Cited by 161
Ohtsuka, T., Buchsbaum, D., Oliver, P., Makhija, S., Kimberly, R., & Zhou, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206290 · Cited by 159
Tepper, C. G., & Seldin, M. F. (1999) · Blood · doi:10.1182/blood.v94.5.1727 · Cited by 154
Fisher, M. J., Virmani, A. K., Wu, L., Aplenc, R., Harper, J. C., Powell, S. M., Rebbeck, T. R., Sidransky, D., Gazdar, A. F., & El‐Deiry, W. S. (2001) · PubMed · Cited by 143
A Role for Mitochondrial Bak in Apoptotic Response to Anticancer Drugs
Wang, G.-Q., Gastman, B., Wieckowski, E. U., Goldstein, L. A., Gambotto, A. A., Kim, T., Fang, B., Rabinovitz, A., Yin, X., & Rabinowich, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103526200 · Cited by 135
Self-citationOkano, H., Shiraki, K., Inoue, H., Kawakita, T., Yamanaka, T., Deguchi, M., Sugimoto, K., Sakai, T., Ohmori, S., Fujikawa, K., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000079328.76631.28 · Cited by 132
Increased expression of cFLIPL in colonic adenocarcinoma
Ryu, B., Lee, M. G., Chi, S.-G., Kim, Y.-W., & Park, J.-H. (2001) · The Journal of Pathology · doi:10.1002/path.835 · Cited by 130
Lacour, S., Micheau, O., Hammann, A., Drouineaud, V., Tschopp, J., Solary, É., & Dimanche‐Boitrel, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206127 · Cited by 130
Seol, D., Li, J., Seol, M. H., Park, S., Talanian, R. V., & Billiar, T. R. (2001) · PubMed · Cited by 129
Bernard, D., Quatannens, B., Vandenbunder, B., & Abbadie, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011183200 · Cited by 121
Kim, Y. S., Schwabe, R. F., Qian, T., Lemasters, J. J., & Brenner, D. A. (2002) · Hepatology · doi:10.1002/hep.1840360627 · Cited by 119
Yang, X., Merchant, M. S., Romero, M. E., Tsokos, M., Wexler, L. H., Kontny, U., Mackall, C. L., & Thiele, C. J. (2003) · PubMed · Cited by 111
Özören, N., Fisher, M. J., Kim, K., Liu, C. X., Genin, A., Shifman, Y., Dicker, D. T., Spinner, N. B., Lisitsyn, N. A., & El‐Deiry, W. S. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.5.917 · Cited by 111
Selective Expression of FLIP in Malignant Melanocytic Skin Lesions
Bullani, R. R., Huard, B., Viard, I., Saurat, J. ‐., French, L. E., Byers, H. R., Irmler, M., & Tschopp, J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01418.x · Cited by 110
Ng, C., & Bonavida, B. (2002) · PubMed · Cited by 108
Frese, S., Pirnia, F., Miescher, D., Krajewski, S., Borner, M., Reed, J. C., & Schmid, R. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206842 · Cited by 101
Ng, C., Zisman, A., & Bonavida, B. (2002) · The Prostate · doi:10.1002/pros.10155 · Cited by 96
Lin, T.-Y., Gu, J. H., Zhang, L., Huang, X., Stephens, L. C., Curley, S. A., & Fang, B. (2002) · PubMed · Cited by 95
Self-citationArmeanu, S., Lauer, U. M., Smirnow, I., Schenk, M., Weiß, T. S., Gregor, M., & Bitzer, M. (2003) · PubMed · Cited by 93
Shetty, S., Gladden, J. B., Henson, E. S., Hu, X., Villanueva, J., Haney, N., & Gibson, S. B. (2002) · APOPTOSIS · doi:10.1023/a:1020031023947 · Cited by 90
French, L. E., & Tschopp, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.891 · Cited by 78
Sah, N. K., Munshi, A., Kurland, J. F., McDonnell, T. J., Su, B., & Meyn, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211010200 · Cited by 70
Gu, J. H., Zhang, L., Huang, X., Lin, T.-Y., Yin, M., Xu, K., Ji, L., Roth, J. A., & Fang, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205582 · Cited by 47
Self-citationA caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells
Peták, I., Vernes, R., Szücs, K. S., Anozie, M., Izeradjene, K., Douglas, L., Tillman, D. M., Phillips, D. C., & Houghton, J. A. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401232 · Cited by 34
Secchiero, P., Milani, D., Gonelli, A., Melloni, E., Campioni, D., Gibellini, D., Capitani, S., & Zauli, G. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103004 · Cited by 28
Zhang, L., Zhu, H., Davis, J. J., Jacob, D., Wu, S., Teraishi, F., Gutierrez‐Barrera, A. M., Wang, Y., & Fang, B. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.696 · Cited by 16
Self-citation
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Szliszka, E., Czuba, Z. P., Domino, M., Mazur, B., Zydowicz, G., & Król, W. (2009) · Molecules · doi:10.3390/molecules · Cited by 1,023
Ceramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
Apoptosis and apoptotic body: disease message and therapeutic target potentials
Xu, X., Lai, Y., & Hua, Z.-C. (2019) · Bioscience Reports · doi:10.1042/bsr20180992 · Cited by 909
Metadata
- Authors
- Zhang, L., & Fang, B.
- Venue
- Cancer Gene Therapy
- Published
- 2004-11-19
- Volume
- 12
- Issue
- 3
- Pages
- 228-237
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2094570524
- Cited by
- 702
- References
- 92
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.